tiprankstipranks
Collegium Pharmaceutical Inc. (COLL)
NASDAQ:COLL
US Market
COLL
Collegium Pharmaceutical
RESEARCH TOOLSreports
Want to see COLL full AI Analyst Report?

Collegium Pharmaceutical (COLL) Ratios

491 Followers

Collegium Pharmaceutical Ratios

COLL's free cash flow for Q1 2026 was $0.61. For the 2026 fiscal year, COLL's free cash flow was decreased by $ and operating cash flow was $0.17. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.71 1.57 0.95 1.17 0.97
Quick Ratio
 1.62 1.48 0.88 1.10 0.86
Cash Ratio
 0.62 0.57 0.14 0.52 0.40
Solvency Ratio
 0.31 0.21 0.17 0.21 0.12
Operating Cash Flow Ratio
 0.76 0.75 0.40 0.60 0.29
Short-Term Operating Cash Flow Coverage
 9.72 10.83 3.17 1.50 0.76
Net Current Asset Value
$ -593.87M$ -663.75M$ -952.49M$ -410.28M$ -559.30M
Leverage Ratios
Debt-to-Assets Ratio
 0.49 0.57 0.52 0.59 0.60
Debt-to-Equity Ratio
 2.59 3.12 3.75 3.45 3.64
Debt-to-Capital Ratio
 0.72 0.76 0.79 0.78 0.78
Long-Term Debt-to-Capital Ratio
 0.71 0.75 0.77 0.71 0.73
Financial Leverage Ratio
 5.29 5.49 7.27 5.85 6.03
Debt Service Coverage Ratio
 2.63 3.29 2.25 1.05 0.78
Interest Coverage Ratio
 1.17 2.27 2.30 2.00 0.53
Debt to Market Cap
 0.66 0.64 0.92 0.64 0.89
Interest Debt Per Share
 30.26 32.26 28.92 22.45 22.83
Net Debt to EBITDA
 0.98 1.72 2.31 1.41 3.09
Profitability Margins
Gross Profit Margin
60.68%59.35%59.76%57.55%45.15%
EBIT Margin
33.72%22.41%27.32%28.07%7.41%
EBITDA Margin
69.23%51.37%54.11%54.40%37.36%
Operating Profit Margin
23.85%23.97%26.91%29.46%7.18%
Pretax Profit Margin
13.59%11.87%15.61%13.36%-6.22%
Net Profit Margin
9.41%8.05%10.96%8.50%-5.39%
Continuous Operations Profit Margin
9.41%8.05%10.96%8.50%-5.39%
Net Income Per EBT
69.25%67.88%70.20%63.59%86.67%
EBT Per EBIT
56.99%49.51%58.02%45.36%-86.58%
Return on Assets (ROA)
4.54%3.79%4.16%4.21%-2.13%
Return on Equity (ROE)
26.74%20.84%30.23%24.64%-12.83%
Return on Capital Employed (ROCE)
15.61%15.38%14.72%24.36%4.50%
Return on Invested Capital (ROIC)
10.51%10.18%9.78%12.21%3.19%
Return on Tangible Assets
8.40%7.47%11.35%8.19%-5.29%
Earnings Yield
6.18%4.28%7.48%4.64%-3.19%
Efficiency Ratios
Receivables Turnover
 3.48 3.69 2.76 3.16 2.53
Payables Turnover
 45.86 29.77 64.59 27.68 72.82
Inventory Turnover
 7.33 7.76 7.15 7.44 5.47
Fixed Asset Turnover
 50.93 48.18 31.34 25.75 17.59
Asset Turnover
 0.48 0.47 0.38 0.50 0.40
Working Capital Turnover Ratio
 2.83 6.97 24.09 17.19 41.72
Cash Conversion Cycle
 146.71 133.62 177.53 151.48 205.76
Days of Sales Outstanding
 104.85 98.82 132.10 115.61 144.07
Days of Inventory Outstanding
 49.82 47.06 51.08 49.05 66.71
Days of Payables Outstanding
 7.96 12.26 5.65 13.19 5.01
Operating Cycle
 154.67 145.88 183.18 164.66 210.77
Cash Flow Ratios
Operating Cash Flow Per Share
 10.32 10.39 6.35 8.14 3.67
Free Cash Flow Per Share
 10.28 10.33 6.30 8.13 3.62
CapEx Per Share
 0.04 0.05 0.05 0.01 0.05
Free Cash Flow to Operating Cash Flow
 1.00 0.99 0.99 1.00 0.99
Dividend Paid and CapEx Coverage Ratio
 273.13 189.27 124.08 595.98 76.59
Capital Expenditure Coverage Ratio
 273.13 189.27 124.08 595.98 76.59
Operating Cash Flow Coverage Ratio
 0.41 0.35 0.24 0.41 0.18
Operating Cash Flow to Sales Ratio
 0.42 0.42 0.32 0.48 0.27
Free Cash Flow Yield
26.90%22.31%21.99%26.41%15.62%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 16.18 23.35 13.36 21.57 -31.39
Price-to-Sales (P/S) Ratio
 1.54 1.88 1.46 1.83 1.69
Price-to-Book (P/B) Ratio
 3.88 4.87 4.04 5.31 4.03
Price-to-Free Cash Flow (P/FCF) Ratio
 3.72 4.48 4.55 3.79 6.40
Price-to-Operating Cash Flow Ratio
 3.66 4.46 4.51 3.78 6.32
Price-to-Earnings Growth (PEG) Ratio
 0.23 -3.12 0.40 -0.07 0.23
Price-to-Fair Value
 3.88 4.87 4.04 5.31 4.03
Enterprise Value Multiple
 3.20 5.38 5.01 4.78 7.62
Enterprise Value
 1.77B 2.16B 1.71B 1.47B 1.32B
EV to EBITDA
 3.20 5.38 5.01 4.78 7.62
EV to Sales
 2.22 2.76 2.71 2.60 2.85
EV to Free Cash Flow
 5.35 6.59 8.43 5.37 10.77
EV to Operating Cash Flow
 5.33 6.55 8.36 5.36 10.63
Tangible Book Value Per Share
 -13.95 -16.20 -25.56 -10.67 -14.97
Shareholders’ Equity Per Share
 9.74 9.51 7.09 5.79 5.76
Tax and Other Ratios
Effective Tax Rate
 0.31 0.32 0.30 0.36 0.13
Revenue Per Share
 24.82 24.62 19.57 16.80 13.71
Net Income Per Share
 2.34 1.98 2.14 1.43 -0.74
Tax Burden
 0.69 0.68 0.70 0.64 0.87
Interest Burden
 0.40 0.53 0.57 0.48 -0.84
Research & Development to Revenue
 0.00 0.00 0.00 0.00 <0.01
SG&A to Revenue
 0.26 0.35 0.29 0.00 0.00
Stock-Based Compensation to Revenue
 0.05 0.05 0.05 0.05 0.05
Income Quality
 4.42 5.24 2.96 5.71 -4.97
Currency in USD